Skip to content

09969.HK

InnoCare Pharma Ltd.

HKSE · Healthcare · Biotechnology · CN

HKD 11.25
−3.60%
Ask drillr

Margins

Gross margin
91.1%
EBITDA margin
38.2%
EBIT margin
37.3%
Net margin
40.5%
FCF margin
9.8%
16.5%
Return on equity
11.8%
Return on assets
12.0%
Return on invested capital
0.29x
Asset turnover
HKD 540.6M
Cash from operations
HKD 4.33
Cash per share

Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Sep 1, 2026